Comparing physical activity measurements in cancer patients
Comparison of the Physical Activity Assessed by an Accelerometer and the International Physical Activity Questionnaire in Oncologic Patients
This study tests whether questionnaires or motion trackers give a better picture of how active cancer patients are during their treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Medicine Greifswald Academic / other |
| Locations | 1 site (Greifswald) |
| Trial ID | NCT05501379 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates the physical activity levels of patients undergoing treatment for lymphoma, pancreatic cancer, or colorectal cancer using both questionnaires and motion trackers. The aim is to compare the effectiveness of these two assessment methods to determine which provides a more accurate measure of physical activity during cancer therapy. By analyzing data collected at various time points, the study seeks to enhance the understanding of physical activity's role in cancer treatment outcomes.
Who should consider this trial
Good fit: Ideal candidates include individuals with a verified diagnosis of lymphoma, colorectal cancer, or pancreatic cancer who are undergoing surgical, chemotherapy, or radiotherapy.
Not a fit: Patients who are pregnant, unable to provide consent, or using a rollator may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved methods for assessing physical activity in cancer patients, potentially enhancing treatment outcomes.
How similar studies have performed: While the assessment of physical activity in cancer patients is a recognized area of interest, this specific comparison of measurement methods is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * verified diagnosis of lymphoma, colorectal or pancreatic cancer * requirement of surgical, chemo or radio therapy * provision of informed consent Exclusion Criteria: * pregnancy * inability to provide consent * use of a rollator
Where this trial is running
Greifswald
- University Medicine Greifswald — Greifswald, Germany (Recruiting)
Study contacts
- Principal investigator: Ali A Aghdassi, Professor — University Medicine Greifswald
- Study coordinator: Ali A Aghdassi, Professor
- Email: ali.aghdassi@med.uni-greifswald.de
- Phone: +493834867230
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.